Managing risk is part of everyday business. But how do you deal with fear? Fear management has been a key challenge at Biogen Idec for the past four years, since a few patients taking the company’s ...

This biopharma firm develops therapies for B-cell malignancies and autoimmune diseases, with a focus on oncology and ...

A University of Toronto-led study has identified a possible biomarker linked to multiple sclerosis (MS) disease progression. The findings, validated in both mouse and in humans, could help to identify ...

Thousands of people in England with a type of multiple sclerosis (MS) are set to benefit from a new treatment on the NHS. Natalizumab, which is given every four weeks as an infusion or injection, has ...

Swiss pharmaceuticals powerhouse Roche announced on Saturday that the company’s experimental multiple sclerosis drug met its primary goal in a late-stage trial in patients with a rare form of the ...

Sanofi SNY announced that the FDA has issued a complete response letter (CRL) to its new drug application (NDA), seeking approval for its investigational Bruton's tyrosine kinase (BTK) inhibitor, ...

In a lab study, a combo of anti-aging drugs appeared to cause a profound loss of the protective coating myelin, which is a ...